ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 163 filers reported holding ADMA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $587,800 | -4.9% | 164,190 | -2.0% | 0.00% | 0.0% |
| Q2 2023 | $618,322 | +5.8% | 167,567 | -5.1% | 0.00% | 0.0% |
| Q1 2023 | $584,165 | -22.6% | 176,485 | -9.3% | 0.00% | 0.0% |
| Q4 2022 | $754,792 | +137.4% | 194,534 | +79.3% | 0.00% | +100.0% |
| Q2 2020 | $318,000 | +1.9% | 108,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $312,000 | +90.2% | 108,500 | +164.6% | 0.00% | – |
| Q4 2019 | $164,000 | -9.9% | 41,000 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $182,000 | +76.7% | 41,000 | +54.1% | 0.00% | – |
| Q2 2019 | $103,000 | +4.0% | 26,600 | +2.3% | 0.00% | – |
| Q1 2019 | $99,000 | +106.2% | 26,000 | +30.0% | 0.00% | – |
| Q4 2018 | $48,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 5,269,155 | $12,804,000 | 12.70% |
| Stonepine Capital Management, LLC | 5,000,000 | $12,150,000 | 5.46% |
| Altium Capital Management LP | 2,883,710 | $7,007,000 | 2.57% |
| AWM Investment Company, Inc. | 5,015,000 | $12,186,000 | 1.85% |
| Potomac Capital Management, Inc. | 482,000 | $1,171,000 | 1.34% |
| Perceptive Advisors | 10,933,387 | $26,568,000 | 0.77% |
| EAM Investors, LLC | 1,427,160 | $3,468,000 | 0.75% |
| Clearline Capital LP | 2,496,297 | $6,066,000 | 0.72% |
| EAM Global Investors LLC | 836,323 | $2,032,000 | 0.54% |
| BOOTHBAY FUND MANAGEMENT, LLC | 8,121,153 | $19,734,000 | 0.49% |